Prevalence and correlates of violence among sexual and injecting partners of people who inject drugs living with HIV in Kenya: a cross-sectional study.
Drug Use
HIV
Kenya
People who inject drugs
Violence
Journal
Harm reduction journal
ISSN: 1477-7517
Titre abrégé: Harm Reduct J
Pays: England
ID NLM: 101153624
Informations de publication
Date de publication:
02 11 2023
02 11 2023
Historique:
received:
09
05
2023
accepted:
23
10
2023
medline:
6
11
2023
pubmed:
3
11
2023
entrez:
3
11
2023
Statut:
epublish
Résumé
In Kenya, violence is common among people who inject drugs (PWID) living with HIV and their sexual and injecting partners and may lead to decreased uptake of HIV services, increased HIV risk behaviors, and increased HIV transmission. Violence is defined as any physical harm, threatened harm, or forced sexual acts inflicted on a person in the past year. Understanding the nature of violence and its correlates among PWID and their partners will inform population-specific public health interventions and policy recommendations. This is a cross-sectional study nested in a prospective cohort study conducted in eight public health centers, methadone clinics, and needle syringe programs in Nairobi, Kilifi, and Mombasa counties in Kenya. 3,302 sexual and/or injecting partners of PWID living with HIV were recruited through assisted partner services and participated in the study. Prevalence and correlates of violence were identified using the Wald test and negative binomial regression. Out of 3302 study participants, 1439 (44%) had experienced violence within the past year. Physical violence was the most common form of violence experienced (35%), followed by being threatened (23%) or subjected to sexual violence (7%). In an adjusted analysis, female participants reported higher experiences of sexual violence (prevalence ratio [PR] = 2.46; 95% confidence interval [CI] 1.62, 3.74; p < 0.001) compared to male participants. In adjusted analysis, coastal residents had a higher experience of overall violence (PR = 1.48; 95% CI 1.27, 1.72; p < 0.001) than those living in Nairobi. This regional effect was relatively stronger among the female respondents (p The study reveals the prevalence of violence among PWID and identifies high-risk sub-groups, including women, specifically for sexual violence, and coastal residents. Tailored interventions addressing their unique needs are essential. A holistic approach that combines violence prevention and response, comprehensive harm reduction, healthcare access, and community support is crucial to address the complex issue of drug use and HIV burden among PWID in Kenya for improved health outcomes.
Sections du résumé
BACKGROUND
In Kenya, violence is common among people who inject drugs (PWID) living with HIV and their sexual and injecting partners and may lead to decreased uptake of HIV services, increased HIV risk behaviors, and increased HIV transmission. Violence is defined as any physical harm, threatened harm, or forced sexual acts inflicted on a person in the past year. Understanding the nature of violence and its correlates among PWID and their partners will inform population-specific public health interventions and policy recommendations.
METHODS
This is a cross-sectional study nested in a prospective cohort study conducted in eight public health centers, methadone clinics, and needle syringe programs in Nairobi, Kilifi, and Mombasa counties in Kenya. 3,302 sexual and/or injecting partners of PWID living with HIV were recruited through assisted partner services and participated in the study. Prevalence and correlates of violence were identified using the Wald test and negative binomial regression.
RESULTS
Out of 3302 study participants, 1439 (44%) had experienced violence within the past year. Physical violence was the most common form of violence experienced (35%), followed by being threatened (23%) or subjected to sexual violence (7%). In an adjusted analysis, female participants reported higher experiences of sexual violence (prevalence ratio [PR] = 2.46; 95% confidence interval [CI] 1.62, 3.74; p < 0.001) compared to male participants. In adjusted analysis, coastal residents had a higher experience of overall violence (PR = 1.48; 95% CI 1.27, 1.72; p < 0.001) than those living in Nairobi. This regional effect was relatively stronger among the female respondents (p
CONCLUSIONS
The study reveals the prevalence of violence among PWID and identifies high-risk sub-groups, including women, specifically for sexual violence, and coastal residents. Tailored interventions addressing their unique needs are essential. A holistic approach that combines violence prevention and response, comprehensive harm reduction, healthcare access, and community support is crucial to address the complex issue of drug use and HIV burden among PWID in Kenya for improved health outcomes.
Identifiants
pubmed: 37919736
doi: 10.1186/s12954-023-00895-7
pii: 10.1186/s12954-023-00895-7
pmc: PMC10623850
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
164Subventions
Organisme : NIDA NIH HHS
ID : R01 DA043409
Pays : United States
Informations de copyright
© 2023. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.
Références
Soc Sci Med. 2005 Sep;61(5):1026-44
pubmed: 15955404
BMC Public Health. 2013 May 28;13:512
pubmed: 23711189
J Epidemiol Community Health. 2015 Jul;69(7):686-92
pubmed: 25691275
Am J Reprod Immunol. 2013 Feb;69 Suppl 1:122-32
pubmed: 23387931
AIDS. 2015 Dec;29 Suppl 3:S195-9
pubmed: 26562809
Harm Reduct J. 2018 May 25;15(1):29
pubmed: 29801494
AIDS Patient Care STDS. 2015 Jan;29 Suppl 1:S42-8
pubmed: 25397666
BMC Public Health. 2021 Aug 14;21(1):1549
pubmed: 34391389
Lancet. 2015 Jan 3;385(9962):55-71
pubmed: 25059947
J Acquir Immune Defic Syndr. 2015 Dec 1;70(4):420-7
pubmed: 26226249
Int J Drug Policy. 2015 Feb;26 Suppl 1:S16-21
pubmed: 25277726
J Int AIDS Soc. 2018 Jul;21 Suppl 5:e25122
pubmed: 30033535
BMJ Open. 2021 Apr 24;11(4):e041083
pubmed: 33895711
Harm Reduct J. 2015 Sep 04;12:27
pubmed: 26337729